Blog 2018-04-20T04:46:44+00:00

FDA Declares Cannabis Drug Epidiolex No Longer A Controlled Substance

April 6th, 2020|Categories: Business|

The U.S. Drug Enforcement Administration (DEA) confirmed that the GW Pharmaceuticals plc (Nasdaq: GWPH) cannabidiol drug Epidiolex is no longer subject to the Controlled Substances Act (CSA). [...]